Nov 25, 2024 06:39AM
Nov 12, 2024 04:05PM
Nov 5, 2024 04:05PM
Nov 1, 2024 07:22AM
Nov 1, 2024 06:40AM
Oct 31, 2024 06:54PM
Oct 18, 2024 05:48AM Lexicon Pharmaceuticals (LXRX) PT Raised to $6 at Leerink Partners
Oct 10, 2024 07:40AM
Sep 7, 2024 08:00PM
Aug 21, 2024 08:02AM
Aug 21, 2024 08:00AM
Aug 1, 2024 04:00PM
Jul 16, 2024 08:03AM
Jul 16, 2024 08:00AM Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA Resubmission
May 26, 2023 10:21AM
May 10, 2023 04:30PM
May 2, 2023 04:00PM
Mar 2, 2023 04:00PM
Nov 9, 2022 04:01PM
Aug 12, 2022 05:21AM
Aug 2, 2022 04:01PM Lexicon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Jul 27, 2022 07:59AM
Jul 27, 2022 07:59AM
Mar 14, 2019 02:02AM
Mar 13, 2019 07:00AM
Mar 1, 2019 08:12AM
Mar 1, 2019 08:01AM
Mar 1, 2019 08:00AM CHMP Recommends Zynquista™ (Sotagliflozin) for the Treatment of Adults With Type 1 Diabetes
Jan 17, 2019 07:22AM
Jan 17, 2019 07:05AM
Nov 29, 2018 09:03AM
Nov 29, 2018 09:00AM
Nov 1, 2018 07:00AM
Jul 30, 2018 07:00AM
May 22, 2018 08:07AM Lexicon Pharma (LXRX), Sanofi (SNY) Announce FDA to Review Zynquista as Potential Treatment for Type 1 Diabetes
May 22, 2018 08:03AM
May 22, 2018 08:01AM
Mar 1, 2017 09:24AM
Feb 28, 2017 06:03PM
Nov 21, 2016 07:00AM
Nov 1, 2016 07:00AM
Oct 31, 2016 04:30PM Lexicon Announces Publication Of TELESTAR Study Results For Telotristat Ethyl In The Journal Of Clinical Oncology
Oct 5, 2016 07:03AM
Oct 5, 2016 07:00AM
Oct 3, 2016 07:00AM
Sep 15, 2016 06:35AM
Sep 15, 2016 06:30AM
Sep 14, 2016 05:46PM
Aug 4, 2016 07:00AM Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Second Quarter Financial Results
Jul 18, 2016 04:04PM

15,423 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All